Options and adjuvants in surgery for pterygium: A report by the American academy of ophthalmology

Keyphrases

• Mitomycin C 100%
• Pterygium 100%
• American Academy of Ophthalmology 100%
• Limbal Autograft 80%
• Conjunctival Autograft 80%
• Excision 40%
• Recurrence Rate 40%
• Recurrent Pterygium 30%
• Bare Sclera 30%
• Primary Pterygium 30%
• Randomized Controlled Trial 20%
• Exposure Time 20%
• Pterygium Surgery 20%
• Patient Preference 10%
• Literature Search 10%
• Treatment Duration 10%
• Surgical Intervention 10%
• Re-epithelialization 10%
• Resource Availability 10%
• Surgical Options 10%
• Increasing Age 10%
• Conjunctival 10%
• Morphological Characteristics 10%
• Route of Administration 10%
• Surgical Excision 10%
• Cochrane Library 10%
• Inclusion Criteria 10%
• PubMed 10%
• Trial Reporting 10%
• Low Quality Data 10%
• Surgeon Preference 10%
• Financial Disclosure 10%
• Conflicting Evidence 10%
• Library Databases 10%
• Surgeon Choice 10%
• C-factor 10%
• Vision Threatening 10%
• Pterygium Recurrence 10%
• Amniotic Membrane 10%
• Amniotic Membrane Graft 10%
• Scleral Thinning 10%
• Amniotic Membrane Transplantation 10%
• Graft Surgery 10%
• Surgical Adjuvants 10%

Medicine and Dentistry

• Ophthalmology 100%
• Pterygium 100%
• Adjuvant 100%
• Mitomycin 100%
• Autograft 80%
• Recurrent Disease 40%
• Recurrence Risk 40%
• Sclera 30%
• Amnion 30%
• Surgeon 20%
• Randomized Controlled Trial 20%
• Pterygium Excision 20%
• Morphology 10%
• Venous Ulcer 10%
• Patient Preference 10%
• Epithelization 10%
• Treatment Duration 10%
• Graft (Surgery) 10%